Ā Mr . ĆZGĆR YĆKSEKDAÄ | Carbonic Anhydrase IX Award | Best Researcher Award
Profile Summary
With a background spanning Cancer Biomedical Science, Biomaterials, and extensive administrative experience in academic settings, I am a dedicated Specialist at Harran University’s Science Technology Application and Research Center. Currently pursuing a Ph.D. in Cancer Biomedical Science, my expertise lies in areas such as anticancer activity, oxidative DNA damage, antioxidants, and apoptosis. My research contributions include articles on molecular cancer biology and projects investigating the effects of compounds like melatonin and osthol on ischemia-reperfusion injury and oxidative stress-related corneal endothelial cell damage. Committed to advancing scientific knowledge and technological applications, I strive to make meaningful contributions in cancer research and beyond.
Professional Profiles
šEducation Information:
Ph.D. Candidate in Cancer Biomedical Science National Cancer Center Graduate School of Cancer Science and Policy Duration: September 2019 – Present. Master of Science (M.S.) in Biomaterial Pusan National University, South Korea Duration: March 2017 – February 2019. Bachelor of Arts (B.A.) in Biomaterial Pusan National University, South Korea Duration: March 2011 – February 2017
š¬Experience Information:
Current Position (Full-Time): Specialist, Harran University Science Technology Application and Research Center Duration: February 2024 – Present Previous Administrative Roles (Full-Time): Administrative Staff, Harran University Faculty of Medicine Duration: March 2022 – Present Other Position, Harran University Faculty of Medicine, Department of Basic Medical Sciences Duration: January 2016 – March 2022
Keywords:
- Anticancer Activity
- Oxidative DNA Damage
- Antioxidants
- Apoptosis
- Metabolomics
- Cancer Biochemistry
šScientific Technological Activity Fields:
- R&D Competency
- Articles
- Molecular Cancer Biology
Selected Articles:
Chemical characterization of extracts from Chelidonium majus L. (Greater celandine) and their pharmacological properties. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors. Metabolite profiles of different extracts from Pelargonium endlicherianum and their biological properties. Mixed-apoptotic effect of Jurinea mesopotamica extract on prostate cancer cells.
š¬ Projects
BAP, ARAÅTIRMACI, Melatonin, Osthol ve Olaparibin Ä°n-Vitro AkciÄer Ä°skemi ReperfĆ¼zyon Hasarı Ćzerine Etkileri, Enforcing Institution: HARRAN ĆNÄ°VERSÄ°TESÄ° (Still continues) . BAP, ARAÅTIRMACI, Oksidatif strese baÄlı geliÅen kornea endotel hĆ¼cre hasarında, Melatonin ve E vitaminin koruyucu etkisinin araÅtırılması., Enforcing Institution: HARRAN ĆNÄ°VERSÄ°TESÄ° (Still continues) .
šTop Noted Publication